Cargando…
Correction: p63 suppresses the ability of pregnancy-identified mammary epithelial cells (PIMECs) to drive HER2-positive breast cancer
Autores principales: | Eyermann, Christopher E., Li, Jinyu, Alexandrova, Evguenia M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8245417/ https://www.ncbi.nlm.nih.gov/pubmed/34193817 http://dx.doi.org/10.1038/s41419-021-03916-0 |
Ejemplares similares
-
p63 suppresses the ability of pregnancy-identified mammary epithelial cells (PIMECs) to drive HER2-positive breast cancer
por: Eyermann, Christopher E., et al.
Publicado: (2021) -
The HSP-RTK-Akt axis mediates acquired resistance to Ganetespib in HER2-positive breast cancer
por: Eyermann, Christopher E., et al.
Publicado: (2021) -
Correction: Pleiotrophin (PTN) Expression and Function in the Mouse Mammary Gland and Mammary Epithelial Cells
por: Rosenfield, Sonia M., et al.
Publicado: (2013) -
TAp63 suppresses mammary tumorigenesis through regulation of the Hippo pathway
por: Su, X, et al.
Publicado: (2017) -
ΔNp63 drives epithelial differentiation in glioma
por: Lu, Jia‐Hao, et al.
Publicado: (2020)